Literature DB >> 25819839

Ruptured aneurysmal subarachnoid hemorrhage in the emergency department: Clinical outcome of patients having a lumbar puncture for red blood cell count, visual and spectrophotometric xanthochromia after a negative computed tomography.

Anne Gangloff1, Linda Nadeau2, Jeffrey J Perry3, Pierre Baril4, Marcel Émond5.   

Abstract

OBJECTIVES: Over the last decade, computed tomography scanners have gained resolution and have become the standard of care in the investigation of neurologically intact patients suffering from acute headache. The added value of the combined assessment of red blood cells count, visual and spectrophotometric xanthochromia, to detect ruptured aneurysmal subarachnoid hemorrhage (ASAH) following a negative head computed tomography (NHCT) was studied.
METHODS: The population consisted of all patients who had cerebrospinal fluid tested for spectrophotometric xanthochromia between 2003 and 2009 identified through the clinical-laboratory database and who met all the inclusion criteria: >14 years old, had an initial Glasgow Coma Score of 15, a non-traumatic acute headache with a suspected subarachnoid hemorrhage recorded in the initial ED differential diagnosis and an initial negative head CT scan.
RESULTS: A total of 706 patients were included. LP identified 5 ASAH (prevalence: 0.7%). In these patients, LP parameters were as follows: high red blood cell count (from 1310 to 63,000×10(6)/L), positive visual xanthochromia in 4 out of 5 ASAH, and positive spectrophotometric xanthochromia in 5 out of 5 ASAH. All ASAH patients were neurologically intact after intervention. No deaths or missed ASAH were reported. Angiographies were performed on 127 patients (19.5%) of which 47 (34.1%) had positive xanthochromia (visual or spectrophotometric).
CONCLUSIONS: Considering the low prevalence of ASAH following an NHCT, intense resources were utilized to identify all 5 ASAH. Lumbar puncture analyses combining red blood cell count, visual and spectrophotometric xanthochromia identified all ASAH, allowing intervention and a positive clinical outcome. Our data support 1) that LP identifies the presence of a ruptured ASAH after an NHCT and 2)` that a guide to define a subpopulation of patients who would benefit from a lumbar puncture after an NHCT would be desirable.
Copyright © 2015. Published by Elsevier Inc.

Entities:  

Keywords:  Aneurysmal subarachnoid haemorrhage; Cerebrospinal fluid; Negative head computed tomography; Spectrophotometric xanthochromia; Visual xanthochromia

Mesh:

Year:  2015        PMID: 25819839     DOI: 10.1016/j.clinbiochem.2015.03.011

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  5 in total

Review 1.  Epigenetic mechanisms of neurodegenerative diseases and acute brain injury.

Authors:  Mario J Bertogliat; Kahlilia C Morris-Blanco; Raghu Vemuganti
Journal:  Neurochem Int       Date:  2019-12-12       Impact factor: 3.921

2.  Is there a role for lumbar puncture in early detection of subarachnoid hemorrhage after negative head CT?

Authors:  Matti Tulla; Tessa Tillgren; Kalle Mattila
Journal:  Intern Emerg Med       Date:  2018-11-24       Impact factor: 3.397

Review 3.  Spontaneous Subarachnoid Hemorrhage: A Systematic Review and Meta-analysis Describing the Diagnostic Accuracy of History, Physical Examination, Imaging, and Lumbar Puncture With an Exploration of Test Thresholds.

Authors:  Christopher R Carpenter; Adnan M Hussain; Michael J Ward; Gregory J Zipfel; Susan Fowler; Jesse M Pines; Marco L A Sivilotti
Journal:  Acad Emerg Med       Date:  2016-09-06       Impact factor: 3.451

Review 4.  Subarachnoid hemorrhage in the emergency department.

Authors:  Sima Patel; Amay Parikh; Okorie Nduka Okorie
Journal:  Int J Emerg Med       Date:  2021-05-12

5.  Toward Understanding Non-coding RNA Roles in Intracranial Aneurysms and Subarachnoid Hemorrhage.

Authors:  Fengzhen Huang; Jiping Yi; Tieqiao Zhou; Xiaoxiang Gong; Hong Jiang; Xiaoxi Yao
Journal:  Transl Neurosci       Date:  2017-05-31       Impact factor: 1.757

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.